Penumbra, Inc. (NYSE:PEN) Receives Average Recommendation of “Hold” from Analysts

Shares of Penumbra, Inc. (NYSE:PEN) have received an average rating of “Hold” from the eighteen research firms that are covering the firm, Marketbeat reports. Fourteen analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 1 year target price among analysts that have issued a report on the stock in the last year is $358.00.

A number of research analysts have recently commented on PEN shares. Evercore ISI reissued an “outperform” rating and set a $340.00 price target on shares of Penumbra in a report on Monday, January 5th. Citigroup lowered shares of Penumbra from a “buy” rating to a “neutral” rating and increased their target price for the company from $350.00 to $374.00 in a research report on Thursday, January 15th. Wall Street Zen cut shares of Penumbra from a “buy” rating to a “hold” rating in a research note on Saturday, January 17th. Piper Sandler downgraded shares of Penumbra from an “overweight” rating to a “hold” rating and set a $374.00 price target on the stock. in a research report on Thursday, January 15th. Finally, William Blair cut shares of Penumbra from an “outperform” rating to a “market perform” rating in a report on Thursday, January 15th.

Penumbra Stock Performance

PEN opened at $358.27 on Friday. The company has a current ratio of 6.73, a quick ratio of 4.18 and a debt-to-equity ratio of 0.02. The business’s 50 day moving average is $319.08 and its 200-day moving average is $277.55. The stock has a market cap of $14.03 billion, a PE ratio of 85.71, a price-to-earnings-growth ratio of 2.20 and a beta of 0.71. Penumbra has a twelve month low of $221.26 and a twelve month high of $362.41.

Penumbra (NYSE:PEN) last issued its quarterly earnings data on Wednesday, November 5th. The company reported $0.97 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.90 by $0.07. The business had revenue of $354.69 million during the quarter, compared to analyst estimates of $340.77 million. Penumbra had a return on equity of 11.35% and a net margin of 12.30%.The business’s revenue for the quarter was up 17.8% compared to the same quarter last year. During the same period in the prior year, the company posted $0.85 EPS. On average, analysts predict that Penumbra will post 3.67 earnings per share for the current year.

Insider Transactions at Penumbra

In other Penumbra news, EVP Johanna Roberts sold 300 shares of the stock in a transaction on Friday, December 5th. The stock was sold at an average price of $300.13, for a total transaction of $90,039.00. Following the completion of the transaction, the executive vice president directly owned 63,836 shares of the company’s stock, valued at approximately $19,159,098.68. This trade represents a 0.47% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Thomas Wilder sold 186 shares of Penumbra stock in a transaction on Friday, January 2nd. The shares were sold at an average price of $310.72, for a total value of $57,793.92. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders have sold 34,144 shares of company stock valued at $10,260,127. 4.20% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Penumbra

Hedge funds and other institutional investors have recently bought and sold shares of the business. Mather Group LLC. bought a new position in shares of Penumbra during the 3rd quarter valued at about $25,000. Newbridge Financial Services Group Inc. bought a new stake in shares of Penumbra in the 2nd quarter worth approximately $30,000. Rothschild Investment LLC bought a new stake in shares of Penumbra in the 3rd quarter worth approximately $40,000. Parkside Financial Bank & Trust lifted its stake in Penumbra by 70.2% during the second quarter. Parkside Financial Bank & Trust now owns 160 shares of the company’s stock valued at $41,000 after purchasing an additional 66 shares during the last quarter. Finally, Farther Finance Advisors LLC boosted its holdings in Penumbra by 27.1% during the fourth quarter. Farther Finance Advisors LLC now owns 178 shares of the company’s stock worth $55,000 after buying an additional 38 shares in the last quarter. 88.88% of the stock is currently owned by institutional investors.

Penumbra Company Profile

Penumbra, Inc is a global healthcare company specializing in the development and manufacture of innovative medical devices that address neurovascular and peripheral vascular conditions. The company focuses on products designed to improve patient outcomes in acute ischemic stroke, aneurysm treatment and peripheral thrombectomy. Penumbra’s technologies are used by interventional neuroradiologists, neurosurgeons and interventional cardiologists in hospitals and clinics around the world.

At the core of Penumbra’s portfolio is its mechanical thrombectomy platform, which includes aspiration catheters and accessory devices engineered to remove blood clots in acute stroke cases.